Background: The Apolipoprotein E (ApoE) polymorphism has been well studied in the adult human population, in part because the
Introduction
Apolipoprotein E (ApoE) is a 299 amino acid protein primarily concerned with lipoprotein and cholesterol metabolism. The human ApoE gene is located on chromosome 19 and has three allelic forms, ε 2, ε 3 and ε 4, encoding different isoforms of the ApoE protein. [1] ApoE is expressed at high level in brain tissue where it is produced mainly by astrocytes which package ApoE with cholesterol for presentation to neurons. [2] [3] ApoE ε 4 is well-known risk factor for sporadic and familial Alzheimer's disease. [4] [5] and is also associated with a poorer outcome following head injury. [6] On the other hand, ApoE ε 2 has been linked with other central nervous system (CNS) disorders including sporadic Parkinson's disease. [7] There is growing evidence that ApoE, lipid metabolism and immune responses are related both systemically and in the CNS. [8] [9] Thus ApoE appears to suppress the production by glia of various pro-inflammatory cytokines, including TNFα, IL1β and IL-6. [10] Accumulating evidence suggests that ApoE ε 3 is more effective than ε 4 in neuronal repair mechanisms and the maintenance of synapses and dendrites. [11] Much of what is known of the role of ApoE in the CNS relates to adult life and older age groups. The influence of ApoE alleles on human development has received little attention despite the importance attached to this polymorphism in relation to brain pathology in later life. We have recently established that there is a high prevalence of prenatal brain damage in Scottish perinatal deaths, both in liveborn and in stillborn infants. [12] [13] In the present study we hypothesised that the absence of one or more ApoE ε 3 alleles might predispose to brain injury in the perinatal period. It is known from population studies that the distribution of ApoE polymorphisms shows geographic and ethnic variations. [14] For this reason we took as our standards for comparison both the data published previously for the adult Scottish population [15] and our own study of the ApoE genotype distribution in Scottish healthy newborns. [16] We report here the ApoE genotype distribution in a geographically matched cohort of perinatal deaths and examine for an association between brain damage and particular ApoE alleles.
Material and Methods
In a Scotland-wide study undertaken in the late 1990s, all perinatal deaths which were at least 24 weeks gestation at birth and less than 7 days at the time of death were identified over a two year period (n=745). The initial purpose of the study was to investigate the epidemiology and neuropathological status of these infant and fetal deaths and to identify any factors which might predispose to brain damage, particularly of prenatal origin. Neonates and fetuses with malformations of the central nervous system (CNS) (n=12) and of the heart (n=28), those with major chromosomal abnormalities (n=28) or with evidence of CNS infection (n=0), and extremely macerated stillbirths (n=118) were all excluded from the study. Consent for the study was withheld in 229 cases and 69 deaths were notified only after the close of the study. After these exclusions, there were 70 liveborn and 191 stillborn infants who qualified for this study. Two pairs of twins were enrolled in this study, one pair liveborn and one stillborn. For the purposes of this study, the ApoE result of the second twin was excluded from analysis. In other multiple pregnancies occurring in the study, only one infant of the siblings had died. No sequential sibling pregnancies were entered in this two year study. Therefore this perinatal ApoE study investigated 261 perinatal deaths, each born within a different family in Scotland during a two year period, representing 35% of the total perinatal deaths in that time. The genotype for each sample was determined from the migration pattern of bands in the gel. After digestion, fragments of different sizes allow ApoE genotyping ( Figure 1 ). ApoE 81bp fragments. ApoE ε 4/4 is characterised by a unique 72bp fragment while ApoE ε 3/3 lacks the 81 and 72bp fragments. Heterozygotes have a combination of different fragments. PCR was repeated for cases in which the band pattern was faint or equivocal until a definite result was obtained. In the small number of cases in which paraffin embedded brain tissue failed to yield a result despite repeated extraction, blocks of spleen sometimes gave a positive result, presumably due to shorter periods of formalin fixation.
When the ApoE analyses were complete for the whole cohort, the cases were divided according to whether they were liveborn or stillborn and analysed for association with evidence of brain damage. The ApoE allele distribution for these perinatal deaths was compared with published data for Scottish adults [15] and healthy liveborn infants. [16] The Scottish adults were healthy, late middle-aged men and women randomly selected from General Practitioner lists in the mid 1980s. The healthy newborns were infants who were born in a single delivery unit within Edinburgh. Blood was collected randomly from the placentas following delivery and all infants were full term and had a birthweight >2kg. No infant required medical care and all left hospital when due to do so. Comparisons of ApoE distribution between populations were made using chi squared analysis. Odds ratios and 95% confidence intervals were calculated for p values of p<0.05. Similarly chi squared analysis was used to determine differences between perinatal deaths showing neuropathological changes and those without such change.
Results
Unequivocal results with clear ApoE banding patterns were obtained for 67 liveborn infants who died at 7 days of age or less, and 186 stillborn fetuses in this study. Both the stillborn and liveborn groups contained a pair of twins and all four babies were found to have an ApoE 2/3 genotype. The second twin of each pair was excluded from further analysis. Spleen blocks were used in 8 cases, all other results being from brain tissue.
The distribution of ApoE alleles and genotypes for the 251 perinatal deaths included in this study is shown in Table 1 A-C, which also includes previously published data for 400 Scottish adults [15] and for 371 healthy newborn infants. [16] Table 1C shows that departure from the Hardy-Weinberg equilibrium is not significant for any of the three populations. Table 2 compares ApoE results in the present study for infants who were liveborn but who died subsequently, and those for stillbirths. Table 1A) . The prevalence of all genotypes possessing one or more ε2 alleles (2/2, 2/3 and 2/4) was higher among perinatal deaths (24%) than among healthy liveborns (16%, OR 1.56, 95% CI 1.43, 1.68) and adults (16%, OR 1.64, 95% CI 1.51, 1.77) ( Table 1B) . The higher prevalence of ApoE ε2 was found both in liveborn and stillborn perinatal deaths (Tables 2A & B) . The prevalence of ApoE adults but the number of cases (n=66) is too small to place reliance on statistical analysis. Table 3 shows the variation in allele distribution across gestational groups. Although there appears to be an increase in e2 in extremely preterm gestations this difference is not statistically significant. (Tables 6 and 7) . 
Discussion
This study reveals significant differences in ApoE allele distribution when comparing perinatal deaths with healthy liveborn infants and with previously published data for the adult population, all in Scotland. Cumming and Robertson [15] showed that ApoE ε 2 was present in 8%, ε 3 in 77% and ε 4 in 15% of 400 adults aged 45-60 years, chosen randomly from North Scotland. Although this is a historical cohort, the distribution of allele frequencies is similar to that of other Caucasian populations in the literature. In the review by Davignon et al [14] of all published data it was found that in 5,805 Caucasians the ApoE allele frequency was 8% for ε 2, 77% for ε 3 and 15% for ε 4, a distribution which is precisely the same as that reported for the Scottish adult population used in this study. The exceptions in this large survey were adults in France and New Zealand who have a raised prevalence of ε2 at 13% and 12% respectively and the Finnish adult population who have a reduced ε 2 (4%) and higher ε 4 (22%) prevalence. [14] These three studies included 223, 426 and 615 subjects respectively and are therefore comparable in size with the present study although the adults were younger than those in the Scottish adult study.
We have shown in 371 healthy newborn infants that the corresponding ApoE distribution for The present study of 251 perinatal deaths shows that ApoE ε 2 is significantly overrepresented in both stillborn and liveborn perinatal deaths, compared with the lower prevalence in both healthy newborn and late middle-aged adults in Scotland. Infants who are born alive but who die in the first week of life also show over-representation of ε 4 and resemble healthy newborns in this respect. While it is possible that these shifts in ApoE distribution have occurred by chance, the numbers in our study are not small. The shift in genotype is also borne out by examination of individual genotypes. However the limitations in comparing newborn with adult populations should be noted in that both ApoE ε 2 and ε 4 are associated with diseases which have their onset in middle life and carry a significant mortality risk. In addition, data from the French, Finish and New Zealand studies quoted above [14] indicate that the prevalence of non-3 ApoE alleles is not entirely consistent in adults.
Support in the literature for a developmental association with different ApoE alleles comes from the small number of studies already available in human infants and pregnancy loss. Zetterberg et al [18] found a decreased prevalence of ε 4 in spontaneous abortions in Crete, 87% of which were earlier than 12 weeks gestation, and proposed that ε 4 may have a protective effect in pregnancy which would be consistent with our findings in healthy newborns. The contrast between ApoE ε 4 prevalence in liveborn and in stillborn (ε4 being higher in the former group), also suggests that ε 4 may have a protective effect. Wright et al [19] showed that ε 4 infants have a better mental developmental index at 2 years of age suggesting that the effects of ε 4 at an early age may be beneficial rather than detrimental. Similar results have been demonstrated in Brazilian children. [20] Other studies suggest that the є 4 allele may be associated with improved cognitive performance and higher educational achievement in early adulthood. [21] [22] In contrast, possession of one or more ApoE ε 2 alleles appears to be detrimental to pregnancy outcome. Relatively little attention has been paid to this, the rarest ApoE allele, perhaps because it is regarded as the "good" gene with respect to Alzheimer's disease and ischaemic heart disease. ApoE ε2 was reported in an early study to be associated with pre-eclampsia [23] but this was not upheld in subsequent studies. [24] [25] ApoE ε 2 is less often transmitted to babies who are small for gestational age [26] and perinatally growth-restricted babies are more likely to develop cardiovascular disease later in life. [27] According to the antagonistic pleiotropic theory of ageing, natural selection favours genes which confer short term benefits at the expense of deterioration in later life. Such opposing effects of the ε 4 allele may result in beneficial effects in early development but detrimental effects in adulthood.
We find no evidence in this study for an association between ApoE genotype and vulnerability for brain damage or haemorrhage in the perinatal period. The relationship between ApoE genotype and hypoxic/ischaemic injury in the brain is complex and conflicting results have been reported in the literature. It seems that ApoE ε 2 is associated with cerebral haemorrhage only in the context of amyloid angiopathy [28] while ε 4 is linked to poorer outcome after haemorrhagic stroke but to better survival following ischaemic damage in the adult. [3] However, no effect of ApoE allele variations was noted in neonatal mouse models transgenic for human ApoE ε 3 and ε 4 and subjected to ischaemic/hypoxic or excitotoxic insults and neuronal survival appeared to be similar in the two animal groups. [29] Our findings for human infants would be in keeping with these animal experiments and extends the results to the ε2 allele.
The role of ApoE in brain tissue is not fully understood but appears to be neuroprotective and immunosuppressive. Protein expression of ApoE is reported to be increased in neurons following a global ischaemic insult in the human brain, but this effect is not influenced by the host genotype in respect of ApoE ε3 or ε4. [30] ApoE ε2 was not included in this study due to the scarcity of this allele. Our findings suggest that ApoE does not display allelespecific neuroprotective variations in the perinatal period.
In summary this study finds that ApoE ε 2 is linked to a poor gestational outcome while ε 4 may confer benefits during pregnancy which make live birth more likely than stillbirth. However we have found no evidence that ApoE status influences the likelihood of sustaining pregnancy-associated brain damage. The absence of one of more ApoE ε 3 alleles did not predispose to brain injury or to haemorrhage. More thorough investigation of the effects of ApoE on the outcome of pregnancy may require paired parent/fetus analysis [26] since it is possible that fetal wellbeing may vary according to the parental source of the 
